Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function.
The present study was designed to determine the role of carbohydrates during naloxone-induced opiate receptor blockade upon the postprandial rise of plasma somatostatin (SLI), insulin and pancreatic polypeptide (PP) levels in response to protein and fat test meals in conscious dogs. Test meals consisting of 50 g liver extract + 50 g sucrose or 50 g corn oil + 50 g sucrose dissolved in 300 ml water were instilled intragastrically, respectively. Additionally, liver extract and fat meals were given with a concomitant intravenous infusion of glucose. To all test meals either naloxone (4 mg) or saline was added. The addition of sucrose to liver extract or the infusion of i.v. glucose during the liver meal abolished the inhibitory effect of naloxone on the rise of postprandial somatostatin levels which has been described recently. The addition of carbohydrate either orally or intravenously to the fat meal resulted in an even stimulatory effect of naloxone upon the rise of postprandial somatostatin levels. Insulin levels were not changed during liver extract + sucrose or i.v. glucose, respectively. When sucrose or i.v. glucose was administered together with the fat meal the addition of naloxone augmented postprandial insulin secretion. Pancreatic polypeptide (PP) release was augmented during the combination of sucrose or i.v. glucose with the fat and liver meal when naloxone was present in the meals. The present data demonstrate that the addition of carbohydrates either orally or intravenously to fat and protein meals modulates the effect of endogenous opiates in the regulation of postprandial somatostatin, insulin and pancreatic polypeptide release in dogs in a way that carbohydrates induce inhibitory mechanisms that are mediated via endogenous opiate receptors.
D000818:Animals; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D004285:Dogs; D004435:Eating; D007328:Insulin / Q000097:blood*; D009270:Naloxone / Q000494:pharmacology; D010191:Pancreatic Polypeptide / Q000097:blood*; D011957:Receptors, Opioid / Q000502:physiology*; D013004:Somatostatin / Q000097:blood*
D004040:Dietary Carbohydrates; D007328:Insulin; D011957:Receptors, Opioid; D009270:Naloxone; D013004:Somatostatin; D010191:Pancreatic Polypeptide